See Which Companies, Clinical Data & Strategies Are Shaping Neoantigen Therapies in 2026
The field is at a clinical inflection point. The 9th International Neoantigen Summit is your unique forum to learn, network and partner with the brightest minds revolutionising the industry.
What will you gain from this?
- Full speaker faculty and a sample of attending companies
- Detailed agenda with clinical trial insights
- Key sessions on validation, combination therapies, and novel modalities
- Who you’ll meet and why it matters
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Takes 30 Seconds – Instant Access To Your Complimentary Copy
Why do People Love the International Neoantigen Summit?
“Very relevant presentations, lots of new clinical data. Good opportunities to reconnect with other attendees.” - Infinitopes
“It was great to get updates about latest neoantigen therapeutic programmes and to get in touch with colleagues from different countries.” - Andarix Pharmaceutical
“Great speaker list and actual topics in the field are addressed. Room for great discussions: after session discussions but also panels and round tables. The audience has a nice size so that it is easy to connect.” - Evaxion Biotech
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
What Can Your Expect in 2026?
With 3 in-depth workshops, 6 brand-new speaking companies, and the latest data shared, this conference is an unmissable opportunity to connect with your neoantigen peers.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.